Skip to main content

Table 2 Expression and inhibitory potency of cystatins against proteases from different aged nodules

From: Cysteine protease and cystatin expression and activity during soybean nodule development and senescence

Cystatin

Expression

Cat-L inhibition

Cat-B inhibition

Active

   

4 weeks

   

Glyma05g28250

+ (22.65)

+ (36.1%)

+ (32.8%)

Glyma13g04250

+ (97.58)

+ (26.4%)

+ (27.6%)

Glyma14g04250

(−) (2.14)

(−)

(−)

Glyma15g36180

+ (26.34)

++ (49.9%)

++ (48.7%)

Glyma20g08800

+ (85.83)

(−)

(−)

14 weeks

   

Glyma05g28250

+ (39.78)

+ (30.6%)

(−)

Glyma13g04250

+ (63.86)

+ (29.7%)

(+) (24.9%)

Glyma14g04250

(+) (12.38)

(+) (21.9%)

(−)

Glyma15g36180

+ (55.64)

(−)

(−)

Glyma20g08800

+ (56.25)

(−)

(−)

Non-active

   

4 weeks

   

Glyma04g10360

(−) (0)

+ (38.6%)

+ (35.3%)

Glyma07g39590

(−) (2.09)

+ (47.5%)

+ (42.3%)

Glyma08g11210

(−) (0)

+ (43.6%)

+ (42.1%)

Glyma18g12240

(−) (0.28)

++ (54.0%)

+ (36.6%)

Glyma13g27980

(−) (0)

+ (33.2%)

+ (42.0%)

14 weeks

   

Glyma04g10360

(−) (0)

+ (39.0%)

+ (28.6%)

Glyma07g39590

(−) (1.23)

++ (51.3%)

+ (34.0%)

Glyma08g11210

(−) (0)

+ (33.5%)

(−)

Glyma18g12240

(−) (0.58)

++ (51.5%)

(+) (22.4%)

Glyma13g27980

(−) (0)

(−)

(−)

  1. ++ strong, + medium. (+) low and (−) no cystatin expression/or activity (tested up to 1 mM). Expression indicated as measured FPKM abundances and activity indicated as% inhibition.